Thermo Fisher Scientific
NYSE: TMO
$596.80
+$36.36 (+6.5%)
Closing price September 17, 2021
24/7 Wall St. looks at some big analyst calls that we have seen so far on Friday, including Alcoa, Comerica, Medallia, Shell Midstream, Thermo Fisher and more.
2 months ago
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including Acenture, NRG Energy, Opendoor Technologies and Thermo Fisher.
6 months ago
Last Updated: 1 month ago
Monday's top analyst upgrades, downgrades and initiations included Agilent Technologies, Antero Midstream, Chewy, Domino's Pizza, eHealth, First Solar, Kraft Heinz, Newmont, Square, Tilray and...
1 year ago
Last Updated: 1 year ago
Friday's top analyst upgrades, downgrades and initiations included Amazon.com, Amgen, Coca-Cola, Danaher, Electronic Arts, IBM, Proofpoint, Sprint, UPS, Uber, Vertex Pharmaceuticals and Visa.
1 year ago
Last Updated: 1 year ago
For health care investors, 2020 looks like a potentially good year after an especially fruitful JPMorgan Healthcare Conference this past week.
1 year ago
Last Updated: 1 year ago
The top analyst upgrades, downgrades and initiations seen on Tuesday included AFL, Agilent, Allergan, Barrick Gold, Cognex, Hilton, Lloyds, MetLife, Slack and Wingstop.
2 years ago
Last Updated: 1 year ago
Health care stocks still have plenty of upside in them. Agilent, Danaher, Thermo Fisher are all stocks to buy.
2 years ago
Last Updated: 1 year ago
The Merrill Lynch team noted that these four stocks had bullish technicals that were most aligned with bullish fundamentals.
2 years ago
Last Updated: 1 year ago
Here are five top health care stocks that provide investors with different avenues to invest in the sector. They all should be solid additions to growth portfolios for 2019.
2 years ago
Last Updated: 1 year ago
The top analyst upgrades, downgrades and initiations seen on Thursday included AT&T, Boeing, Hilton, KB Home, Microsoft, Norfolk Southern, Pandora and UPS.
2 years ago
Last Updated: 4 months ago
Here are the 15 companies that appear most likely to enter or get back into the $100 billion market capitalization club among U.S. stocks.
3 years ago
Last Updated: 1 year ago
Managers of the UBS Q-GARP portfolio continue searching for high-quality U.S. growth companies that are trading at attractive valuations. They maintain that recent volatility in the market has had no...
3 years ago
Last Updated: 1 year ago
According to a recent analyst report by Janney, the National Institute of Health budget that was approved last Friday could be a big boost for some select biopharma stocks.
3 years ago
Last Updated: 1 year ago
According to Merrill Lynch, the health care sector should act as a good hedge against volatility. Even biotech was shown to offer growth at a reasonable price.
4 years ago
Last Updated: 1 year ago
The include BioCryst Pharmaceuticals, Exxon Mobil, Fiat Chrysler Automobiles, Hewlett Packard Enterprise, IAMGOLD, Mallinckrodt and Rockwell Collins.
4 years ago
Last Updated: 1 year ago